Prospective Randomized Trial of Rotor Ablation vs Conventional Ablation for Persistent Atrial Fibrillation: REAFFIRM Trial
Journal of the American Heart Association · 2025-07 · 14 (13)
DOI: 10.1161/jaha.121.022346 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Heart Association, 2025-07. Verfasst von Johannes Brachmann und 8 weiteren Autor:innen. Beteiligte Einrichtung: Klinikum Coburg Sana Medical School, University of Split School of Medicine Coburg Germany. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Pulmonary Veins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Pulmonary vein isolation (PVI) is the cornerstone therapy for symptomatic drug‐refractory atrial fibrillation yet is not curative in a large segment of patients. Focal and rotational drivers are proposed to be involved in atrial fibrillation mechanisms but their ablation has produced variable outcomes. REAFFIRM (The Randomized Evaluation of Atrial Fibrillation Treatment with Focal Impulse and Rotor Modulation Guided Procedures) trial (NCT‐02274857) objective was to compare the safety and effectiveness of conventional ablation with and without Focal Impulse and Rotor Modulated (FIRM) ablation, guided by global basket mapping, for the treatment of persistent atrial fibrillation.
Methods
Three hundred seventy‐five patients were enrolled and randomized at 18 centers. The Intent‐to‐Treat population consisted of 350 patients (171 FIRM, 179 Conventional). Primary effectiveness was defined as single procedure freedom from atrial fibrillation/atrial tachycardia recurrence at 3 to 12 months post index procedure.
Results
Three hundred twenty‐four patients completed the 12‐month follow‐up. Patients in the FIRM arm had a larger left atrium ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Klinikum Coburg Sana Medical School, University of Split School of Medicine Coburg Germany.
- Kardiologische Gemeinschaftspraxis am Park Sanssouci Potsdam Germany.
- Ohio State University Columbus OH.
- Arizona Heart Rhythm Center Phoenix AZ.
- Loyola University Chicago Maywood IL.
- Abbott Plymouth MN.
ORCID-Profile: Johannes Brachmann, John Hummel, David Wilber, Shlomo Shpun, Anne Sarver, Tamás Szili-Törok
Zitieren
APA
Brachmann, J., Vogtmann, T., Hummel, J., Swarup, V., Wilber, D., Rapkin, J., Shpun, S., Sarver, A., & Szili-Törok, T. (2025). Prospective Randomized Trial of Rotor Ablation vs Conventional Ablation for Persistent Atrial Fibrillation: REAFFIRM Trial. Journal of the American Heart Association, 14(13). https://doi.org/10.1161/jaha.121.022346
Vancouver
Brachmann J, Vogtmann T, Hummel J, Swarup V, Wilber D, Rapkin J, et al. Prospective Randomized Trial of Rotor Ablation vs Conventional Ablation for Persistent Atrial Fibrillation: REAFFIRM Trial. Journal of the American Heart Association. 2025;14(13). doi:10.1161/jaha.121.022346
BibTeX
@article{Brachmann2025,
author = {Brachmann, Johannes and Vogtmann, Thomas and Hummel, John and Swarup, Vijay and Wilber, David and Rapkin, Joshua and Shpun, Shlomo and Sarver, Anne and Szili-Törok, Tamás},
title = {Prospective Randomized Trial of Rotor Ablation vs Conventional Ablation for Persistent Atrial Fibrillation: REAFFIRM Trial},
journal = {Journal of the American Heart Association},
year = {2025},
volume = {14},
number = {13},
doi = {10.1161/jaha.121.022346}
}
EUVIMED